Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial
about
Recombinant house dust mite allergens.Cellular mechanisms of chronic cell-mediated allergic conjunctivitis.CD4CD25 regulatory T lymphocytes in allergy and asthma.In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy.Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible Biological Activity But Retained ImmunogenicityAllergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analysesHouse dust allergy and immunotherapy.Immunotherapy - Vaccines for allergic diseases.Rational design of hypoallergens applied to the major cat allergen Fel d 1.Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction.Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy.The efficacy of allergen immunotherapy with cat dander in reducing symptoms in clinical practiceHistamine reactivity of the skin.Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial.Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges.Immunotherapy for pet allergies.Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy.
P2860
Q34361546-B42826A5-DB07-4FDC-B015-CB1409908FA0Q34669386-B8838217-116F-48B1-ACC3-99E5E279E882Q36169760-F2650CCD-1041-445E-9D08-8BAC2377D86CQ36290441-8B6072E1-AE00-4D4E-ADD2-7A064022AC4CQ36370976-67941F28-D649-41BA-9E49-BB2C9D65C0A8Q36411170-DFE1953F-BE78-4CB8-B808-67D21F030E2DQ36863569-03857688-875E-403B-9F2E-6791A426503EQ39244341-D88A27D5-9DBC-49F4-A65A-95E26F113548Q39366990-C78AE699-5B82-4F62-BE90-9880C3D9EFD7Q42143464-8485D39E-7676-40D8-8492-7287F375E5DEQ42153928-B0C6D6BC-52CF-4434-83AE-1F2AF7B96B1AQ42560584-AC4C5580-58C1-4D95-ACDD-5E377D84B32FQ43605733-2F601E0C-64DA-44A8-9B5E-0CF4948B192FQ43724345-3F223453-9DE9-4755-82AC-CBA39888F029Q44545292-8AD64EAA-F3F9-4CC3-B1B9-5CCAD94B1EFFQ47602618-8AA66508-D43C-4EDE-BFD0-1C8943EC57F7Q47697735-5C337465-4C6D-4927-9289-7785579D7210Q53626399-85536A8C-A68C-4F3E-A57D-8A8B0153EB2E
P2860
Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Clinical efficacy of specific ...... blind placebo-controlled trial
@ast
Clinical efficacy of specific ...... blind placebo-controlled trial
@en
Clinical efficacy of specific ...... blind placebo-controlled trial
@nl
type
label
Clinical efficacy of specific ...... blind placebo-controlled trial
@ast
Clinical efficacy of specific ...... blind placebo-controlled trial
@en
Clinical efficacy of specific ...... blind placebo-controlled trial
@nl
prefLabel
Clinical efficacy of specific ...... blind placebo-controlled trial
@ast
Clinical efficacy of specific ...... blind placebo-controlled trial
@en
Clinical efficacy of specific ...... blind placebo-controlled trial
@nl
P2093
P1476
Clinical efficacy of specific ...... blind placebo-controlled trial
@en
P2093
P356
10.1046/J.1365-2222.1997.1220903.X
P407
P577
1997-08-01T00:00:00Z